US OptionsDetailed Quotes

RXST250516P17500

Watchlist

0.00
0.000.00%

15min DelayClose Apr 25 09:30 ET

0.00High0.00Low

RxSight Stock Discussion

Django1

Apr 24 07:31

$RxSight (RXST.US)$ 👀

Teddy123

Apr 3 12:55

RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance

$RxSight (RXST.US)$
RxSight Cuts 2025 Revenue Target by $25M Despite Strong Lens Sales Growth

103542837

Mar 17 22:39

$RxSight (RXST.US)$ are wee seeing an upward trend now

103542837

Mar 5 00:57

$RxSight (RXST.US)$ why was pre market up by 15% but now down so much

🔔 RA Capital Q1 ‘24* Holdings Released... 🐳

» Holdings: 75
» Holdings in Top 20: 70.21%
» Qtr over Qtr Change**: +21.81%
Top Holdings:
$Ascendis Pharma A/S (ASND.US)$
$Vaxcyte (PCVX.US)$
$Legend Biotech (LEGN.US)$
$Janux Therapeutics (JANX.US)$
$Aerovate (AVTE.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Evolent Health (EVH.US)$
$NewAmsterdam Pharma (NAMS.US)$
$RxSight (RXST.US)$
$TYRA BIOSCIENCES, INC. (TYRA.US)$
$Edgewise Therapeutics (EWTX.US)$
$4D Molecular Therapeutics (FDMT.US)$
$Biogen (BIIB.US)$
$PepGen (PEPG.US)$
...

Moomoo AI

Feb 5, 2024 18:22

The recent insider sale of RxSight shares and the absence of insider purchases over the last year raise concerns about the company's outlook. Despite significant insider ownership, the lack of insider buying does not inspire confidence in the company's prospects.

Trade Alert: Independent Director Of RxSight William Link Has Sold Stock

moom lives

Dec 13, 2023 21:31

Stocks making the biggest moves before the bell:

$Tesla (TSLA.US)$ — Shares fell 1.2% after U.S. safety regulators said Tesla will recall more than 2 million vehicles to fix issues with its driver assistance system. The electric vehicle maker will send out a software update to fix the problem, which impacts models Y, S, 3 and X produced between Oct. 5, 2012 and Dec. 7, 2023.
$Pfizer (PFE.US)$ — The biopharmaceutical stock dropped 7.4% after Pfizer issued full-year guidance for adjusted earnings ...

Moomoo AI

Dec 13, 2023 18:55

Investor confidence in RxSight appears bolstered by its high future revenue growth expectations and strong performance, resulting in a high P/S ratio. Investors seem willing to pay more for anticipated growth.

RxSight, Inc. (NASDAQ:RXST) Stocks Shoot Up 45% But Its P/S Still Looks Reasonable

Moomoo AI

Dec 12, 2023 18:54

The company seems well equipped to manage its cash burn, potentially securing more funds for its expansion with minimal dilution or borrowing. Revenue growth paints a bright future for the firm, while the slight reduction in cash burn isn't concerning, given its mid-term expenditure needs.